"Im Städtischen Krankenhaus arbeiten rund 2.000 Mitarbeiter*innen täglich Hand in Hand für Ihre Gesundheit. Wer ins Städtische Krankenhaus kommt, erfährt Hilfe – fürsorglich, menschlich und verantwortungsbewusst. Mit diesem Anspruch versorgen wir jährlich 26.000 stationäre und 46.000 ambulante Patient*innen. Die Schwerpunkte unserer Arbeit liegen in den Bereichen der Notfall- und Unfallversorgung, Geriatrie, Chirurgie, Hämatologie/ Onkologie, Urologie, Intensivmedizin, Gynäkologie und Geburtshilfe. Zu unseren Kliniken und Zentren gehört unter anderem unsere Frauenklinik, die zu den geburtenstärksten Kliniken in ganz Schleswig-Holstein gehört."

During the past decade, Staedtisches Krankenhaus Kiel conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Staedtisches Krankenhaus Kiel" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "German CLL Study Group" with 3 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "Mukoviszidose Institut gGmbH" with 2 trials sponsored and "University of Ulm" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Staedtisches Krankenhaus Kiel" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Masaryk University" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Staedtisches Krankenhaus Kiel" are "Lymphoma" (4 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Cystic Fibrosis" (3 trials), "Acute Myeloid Leukemia" (2 trials) and "Acute Myeloid Leukemia (AML)" (1 trials). Many other conditions were trialed in "Staedtisches Krankenhaus Kiel" in a lesser frequency.

Most popular intervention types in "Staedtisches Krankenhaus Kiel" are "Drug" (19 trials), "Radiation" (7 trials), "Biological" (6 trials), "Procedure" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (5 trials), "filgrastim" (5 trials) and "vincristine sulfate" (5 trials). Other intervention names were less common.

The vast majority of trials in "Staedtisches Krankenhaus Kiel" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Staedtisches Krankenhaus Kiel". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Staedtisches Krankenhaus Kiel, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Staedtisches Krankenhaus Kiel, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".